In the Koga et al. study, the number of Th17 cells in the peripheral blood and skin lesions of patients with AD was assessed, the effect of IL-17 on the production of cytokines/chemokines, and vascular endothelial growth factor (VEGF) by keratinocytes was investigated. This evidence concerns the gene IL17A and Alzheimer disease.